Iotrolan
From Wikipedia, the free encyclopedia
Systematic (IUPAC) name | |
---|---|
2,4,6-triiodo-5-{N-methyl-2-[methyl({2,4,6-triiodo-3,5-bis[(1,3,4-trihydroxybutan-2-yl)carbamoyl]phenyl})carbamoyl]acetamido}-1-N,3-N-bis(1,3,4-trihydroxybutan-2-yl)benzene-1,3-dicarboxamide | |
Clinical data | |
AHFS/Drugs.com | International Drug Names |
Pregnancy cat. | Contraindicated |
Legal status | ℞ Prescription only |
Identifiers | |
CAS number | 79770-24-4 |
ATC code | V08AB06 |
PubChem | CID 3738 |
UNII | 16FL47B687 |
KEGG | D01714 |
ChEMBL | CHEMBL1200555 |
Chemical data | |
Formula | C37H48I6N6O18 |
Mol. mass | 1626.23 g/mol |
(what is this?) (verify) | |
Iotrolan (trade name Isovist) is a radiocontrast agent, a substance used to improve the visibility of body structures on images obtained by X-ray techniques. It is particularly used to image spaces surrounding the central nervous system, such as the ventricles, after injection into the cerebrospinal fluid.[1] It can also be used to image joint spaces and in endoscopic retrograde cholangiopancreatography (ERCP).[citation needed]
Chemically, the substance is a dimer of triiodinated isophthalic acid derivatives.
References
|
This article is issued from Wikipedia. The text is available under the Creative Commons Attribution/Share Alike; additional terms may apply for the media files.